Merck, Johnson & Johnson Share Losses Lead Dow's 180-Point Fall

Dow Jones01-08 22:53

DJ Merck, Johnson & Johnson Share Losses Lead Dow's 180-Point Fall

This article was automatically generated by MarketWatch using technology from Automated Insights.

The Dow Jones Industrial Average is declining Wednesday morning with shares of Merck and Johnson & Johnson seeing the biggest losses for the price-weighted average.

The Dow (Dow Jones Industrial Average) was most recently trading 180 points, or 0.4%, lower, as shares of Merck (Merck & Co. Inc.) and Johnson & Johnson (Johnson & Johnson) are contributing to the blue-chip gauge's intraday decline.

Merck's shares have declined $2.12 (2.1%) while those of Johnson & Johnson are down $2.93, or 2.0%, combining for a roughly 31-point drag on the Dow.

Other components contributing significantly to the decline include Walt Disney (Walt Disney Co.), Boeing (Boeing Co.), and Home Depot (Home Depot Inc.).

A $1 move in any of the Dow's 30 components results in a 6.15-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled January 8, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

January 08, 2025 09:53 ET (14:53 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment